30 related articles for article (PubMed ID: 3978644)
1. Hyaluronic acid in viscous malignant mesothelioma pleural effusion.
Cheah HM; Fitzgerald D; Louw A; Creaney J; Lee YCG
Respirol Case Rep; 2021 Jan; 9(1):e00694. PubMed ID: 33304592
[TBL] [Abstract][Full Text] [Related]
2. Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer.
Tahkola K; Ahtiainen M; Mecklin JP; Kellokumpu I; Laukkarinen J; Tammi M; Tammi R; Väyrynen JP; Böhm J
Sci Rep; 2021 Jun; 11(1):12216. PubMed ID: 34108626
[TBL] [Abstract][Full Text] [Related]
3. The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44.
Zhao C; Thompson BJ; Chen K; Gao F; Blouw B; Marella M; Zimmerman S; Kimbler T; Garrovillo S; Bahn J; Huang L; Huang Z; Shepard HM; Rosengren S; Thanos CD; Maneval DC
Oncotarget; 2019 Nov; 10(61):6561-6576. PubMed ID: 31762938
[TBL] [Abstract][Full Text] [Related]
4. Coordination-Responsive Longitudinal Relaxation Tuning as a Versatile MRI Sensing Protocol for Malignancy Targets.
Zhang K; Cheng Y; Ren W; Sun L; Liu C; Wang D; Guo L; Xu H; Zhao Y
Adv Sci (Weinh); 2018 Sep; 5(9):1800021. PubMed ID: 30250780
[TBL] [Abstract][Full Text] [Related]
5. CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.
Cortes-Dericks L; Schmid RA
Respir Res; 2017 Apr; 18(1):58. PubMed ID: 28403901
[TBL] [Abstract][Full Text] [Related]
6. Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy.
Rangel MP; de Sá VK; Martins V; Martins JR; Parra ER; Mendes A; Andrade PC; Reis RM; Longatto-Filho A; Oliveira CZ; Takagaki T; Carraro DM; Nader HB; Capelozzi VL
Braz J Med Biol Res; 2015 Jun; 48(6):557-67. PubMed ID: 25992645
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic role of glycosaminoglycans in pleural effusions: a pilot study.
Vavetsi R; Bonovas S; Polizou P; Papanastasopoulou C; Dougekou G; Sitaras NM
BMC Pulm Med; 2009 Feb; 9():9. PubMed ID: 19226451
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan synthase expression in pleural malignant mesotheliomas.
Kanomata N; Yokose T; Kamijo T; Yonou H; Hasebe T; Itano N; Kimata K; Ochiai A
Virchows Arch; 2005 Mar; 446(3):246-50. PubMed ID: 15731923
[TBL] [Abstract][Full Text] [Related]
9. Expression of human hyaluronan synthases in response to external stimuli.
Jacobson A; Brinck J; Briskin MJ; Spicer AP; Heldin P
Biochem J; 2000 May; 348 Pt 1(Pt 1):29-35. PubMed ID: 10794710
[TBL] [Abstract][Full Text] [Related]
10. Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein.
Fries H; Elsässer HP; Mahlbacher V; Neumann K; Kern HF
Virchows Arch; 1994; 424(1):7-12. PubMed ID: 7526947
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of malignant pleural effusion.
Hausheer FH; Yarbro JW
Cancer Metastasis Rev; 1987; 6(1):23-40. PubMed ID: 2439221
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells.
Heldin P; Asplund T; Ytterberg D; Thelin S; Laurent TC
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):165-70. PubMed ID: 1567364
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
14. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
15. Cytological diagnosis of malignant mesothelioma--improvement by additional analysis of hyaluronic acid in pleural effusions.
Welker L; Müller M; Holz O; Vollmer E; Magnussen H; Jörres RA
Virchows Arch; 2007 Apr; 450(4):455-61. PubMed ID: 17377812
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of pleural malignant mesothelioma in life--a practical approach.
Whitaker D; Shilkin KB
J Pathol; 1984 Jul; 143(3):147-75. PubMed ID: 6379132
[TBL] [Abstract][Full Text] [Related]
17. [Hyaluronic acid. Usefulness and perspectives of its serum assay].
Levesque H; Chassagne P; Frebourg T; Delpech B
Presse Med; 1990 May; 19(21):1001-5. PubMed ID: 2141140
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma.
Roboz J; Greaves J; Silides D; Chahinian AP; Holland JF
Cancer Res; 1985 Apr; 45(4):1850-4. PubMed ID: 3978644
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
